Citation: Rh. Stern et al., ATORVASTATIN DOES NOT PRODUCE A CLINICALLY SIGNIFICANT EFFECT ON THE PHARMACOKINETICS OF TERFENADINE, Journal of clinical pharmacology, 38(8), 1998, pp. 753-757
Citation: Rh. Stern et al., CIMETIDINE DOES NOT ALTER ATORVASTATIN PHARMACOKINETICS OR LDL-CHOLESTEROL REDUCTION, European Journal of Clinical Pharmacology, 53(6), 1998, pp. 475-478
Authors:
STERN RH
YANG BB
HORTON M
MOORE S
ABEL RB
OLSON SC
Citation: Rh. Stern et al., RENAL DYSFUNCTION DOES NOT ALTER THE PHARMACOKINETICS OR LDL-CHOLESTEROL REDUCTION OF ATORVASTATIN, Journal of clinical pharmacology, 37(9), 1997, pp. 816-819
Citation: Rh. Stern et Rb. Abel, RATE OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-B CHANGES ON INITIATION AND DISCONTINUATION OF ATORVASTATIN TREATMENT, Journal of clinical pharmacology, 37(4), 1997, pp. 291-296
Citation: Rh. Stern et H. Rasmussen, LEFT-VENTRICULAR EJECTION - MODEL SOLUTION BY COLLOCATION, AN APPROXIMATE ANALYTICAL METHOD, Computers in biology and medicine, 26(3), 1996, pp. 255-261
Authors:
STERN RH
ZANZI I
ROLAND S
ROSENTHAL A
PERLMAN P
MARGOULEFF D
Citation: Rh. Stern et al., SCINTIGRAPHIC CEREBRAL SPINAL-FLUID LEAK STUDY IN A CHILD WITH RECURRENT MENINGITIS AFTER RESECTION OF A FRONTAL MENINGOCELE, Clinical nuclear medicine, 20(2), 1995, pp. 136-139